Drug intelligence / Profile preview

FLT3-IL7-CAR-gamma delta T cells

Development stage
Preclinical
Lead developer
Soochow University
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
01

Overview

**FLT3-IL7-CAR-gamma delta T cells** are an experimental, IL-7-armored FLT3-directed γδ CAR-T cell product evaluated preclinically for acute myeloid leukemia. The engineered γδ T cells express a CAR that recognizes FMS-like tyrosine kinase 3 and co-express interleukin-7 to support T-cell survival and persistence. The construct was compared with non-armored FLT3-CAR-γδT cells and IL-2-armored FLT3-CAR-γδT cells in AML cell-line, primary AML-cell, and mouse xenograft experiments; the reported study identified the IL-2-armored comparator as the most active construct overall. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC13024764/))

Other names
FLT3-IL7-CAR-gamma delta T cellsFLT-3-IL7-CAR-gamma delta T cellsFLT 3-IL7-CAR-gamma delta T cellsFLT3-IL7-CAR-γδT cells
02

Targets

IL7R (Interleukin-7 Receptor)FLT3 (Fms related receptor tyrosine kinase 3)

Beyond the preview

Go deeper on FLT3-IL7-CAR-gamma delta T cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FLT3-IL7-CAR-gamma delta T cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call